Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,645,869 |
|
|||||
| News | - | ||||||
| Day High | 29.27 | Low High |
|||||
| Day Low | 25.67 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| PTC Therapeutics Inc | PTCT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 3.21 | 12.59% | 28.70 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.00 | 25.67 | 29.27 | 28.57 | 25.49 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,708 | 1,645,869 | $ 28.22 | $ 46,448,734 | - | 17.53 - 59.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:44:50 | 35 | $ 28.65 | USD |
PTC Therapeutics (PTCT) Options Flow Summary
PTC Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.19B | 76.61M | - | 1.07B | -626.6M | -8.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PTC Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTCT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.01 | 29.27 | 23.995 | 25.41 | 1,383,879 | 4.69 | 19.53% |
| 1 Month | 29.01 | 29.42 | 23.995 | 26.22 | 847,154 | -0.31 | -1.07% |
| 3 Months | 25.57 | 32.905 | 23.58 | 27.62 | 867,264 | 3.13 | 12.24% |
| 6 Months | 23.46 | 32.905 | 17.53 | 25.66 | 1,065,238 | 5.24 | 22.34% |
| 1 Year | 51.20 | 59.84 | 17.53 | 30.54 | 1,040,847 | -22.50 | -43.95% |
| 3 Years | 46.16 | 59.84 | 17.53 | 36.56 | 762,683 | -17.46 | -37.82% |
| 5 Years | 38.65 | 70.82 | 17.53 | 40.94 | 718,707 | -9.95 | -25.74% |
PTC Therapeutics Description
| PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology. |
